Evaluation of hematological indices in patients with colon cancer

Abstract

I read with interest the formerly published paper entitled “Retrospective evaluation of platelet indices and RAS mutations in patients with colon cancer” by Şanlıer et al. (1). In that published paper, the authors evaluated the hematological indices in colon cancer patients and their relationships between RAS mutations. It has been noticed that the authors evaluated neutrophil to lymphocyte ratio (NLR), mean platelet volume (MPV), platelet to lymphocyte ratio (PLR) and red cell distribution width (RDW) as hematological indices in colon cancer cases. I would like to thank the authors for valuable contribution to the literature for especially topic on colon cancer.